Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature
Elliot Berinstein, Jessica L. Sheehan, Janson Jacob, Calen A. Steiner, Ryan W. Stidham, Carol Shannon, Shrinivas Bishu, Jake Levine, Shirley Cohen‐Mekelburg, Akbar K. Waljee, Peter Higgins, Jeffrey Berinstein
Topics & Concepts
VedolizumabMedicineTofacitinibUstekinumabInternal medicineInflammatory bowel diseaseCochrane LibraryUlcerative colitisNatalizumabCrohn's diseaseAdalimumabGastroenterologyOncologyRandomized controlled trialDiseaseRheumatoid arthritisInflammatory Bowel DiseaseClick Chemistry and ApplicationsBiosimilars and Bioanalytical Methods